These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 3147426

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Cyclosporine and metabolites in blood from renal allograft recipients with nephrotoxicity, rejection, or good renal function: comparative high-performance liquid chromatography and monoclonal radioimmunoassay studies.
    Rosano TG, Pell MA, Freed BM, Dybas MT, Lempert N.
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):330-8. PubMed ID: 3284076
    [No Abstract] [Full Text] [Related]

  • 24. Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study.
    Oberbauer R, Kreis H, Johnson RW, Mota A, Claesson K, Ruiz JC, Wilczek H, Jamieson N, Henriques AC, Paczek L, Chapman J, Burke JT, Rapamune Maintenance Regimen Study Group.
    Transplantation; 2003 Jul 27; 76(2):364-70. PubMed ID: 12883194
    [Abstract] [Full Text] [Related]

  • 25. Renal retransplants: effect of primary allograft nephrectomy on early function, acute rejection and outcome.
    Douzdjian V, Rice JC, Carson RW, Gugliuzza KK, Fish JC.
    Clin Transplant; 1996 Apr 27; 10(2):203-8. PubMed ID: 8664520
    [Abstract] [Full Text] [Related]

  • 26. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May 27; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 27. [Completely reversed acute rejection episodes do not influence the long-term renal allograft survival].
    Wu JY, Chen JH, Wang YM, Zhang JG, Zhu C, Wang SY, Zhang P, Huang HF, He Q.
    Zhonghua Yi Xue Za Zhi; 2003 Jan 25; 83(2):106-9. PubMed ID: 12812676
    [Abstract] [Full Text] [Related]

  • 28. Spanish experience with cyclosporine.
    Pascual J, Marcén R, Burgos FJ, Villafruela JJ, Teruel JL, Mampaso F, Quereda C, Ortuño J.
    Transplant Proc; 2004 Mar 25; 36(2 Suppl):117S-119S. PubMed ID: 15041319
    [Abstract] [Full Text] [Related]

  • 29. Monitoring of renal allografts by Doppler ultrasound.
    Ubhi CS, Irving HC, Norwood HM, Guillou PJ, Giles GR.
    Ann R Coll Surg Engl; 1987 Sep 25; 69(5):229-32. PubMed ID: 3314635
    [Abstract] [Full Text] [Related]

  • 30. Cyclosporine alone or in combination with prednisone in cadaveric renal transplantation.
    Thiel G, Harder F, Loertscher R, Brünisholz M, Landmann J, Brunner F, Follat F, Wenk M, Mihatsch M.
    Transplant Proc; 1984 Oct 25; 16(5):1187-90. PubMed ID: 6385374
    [Abstract] [Full Text] [Related]

  • 31. Three-years experience with Neoral C2 monitoring adjusted to a target range of 500-600 ng/ml in long-term renal transplant recipients receiving dual immunosuppressive therapy.
    Carstens J.
    Scand J Urol Nephrol; 2008 Oct 25; 42(3):286-92. PubMed ID: 18432535
    [Abstract] [Full Text] [Related]

  • 32. Optimal cyclosporine plasma levels decline with time of therapy.
    Klintmalm G, Säwe J, von Bahr C, Ringdén O, Lundgren G, Wilczek H, Tydén G, Groth CG.
    Transplant Proc; 1984 Oct 25; 16(5):1208-11. PubMed ID: 6385380
    [Abstract] [Full Text] [Related]

  • 33. Ciclosporin monitoring in kidney-transplanted children: high-performance liquid chromatography versus radioimmunoassay.
    Khoss AE, Hamilton G, Illievich V, Mühlbacher F, Roth E, Steger H, Wladika W, Howanietz H, Balzar E.
    Child Nephrol Urol; 1984 Oct 25; 9(1-2):42-5. PubMed ID: 3075152
    [Abstract] [Full Text] [Related]

  • 34. Effect of renal allograft dysfunction upon cyclosporine trough levels in host blood.
    Arnold AN, Waltzer WC, Anaise D, Weinstein SW, Rapaport FT.
    Transplantation; 1985 Dec 25; 40(6):605-10. PubMed ID: 3907030
    [Abstract] [Full Text] [Related]

  • 35. Update on topical cyclosporin A. Background, immunology, and pharmacology.
    Belin MW, Bouchard CS, Phillips TM.
    Cornea; 1990 Jul 25; 9(3):184-95. PubMed ID: 2197063
    [Abstract] [Full Text] [Related]

  • 36. The impact of steady-state cyclosporine concentrations on renal allograft outcome.
    Dunn J, Grevel J, Napoli K, Lewis RM, Van Buren CT, Kahan BD.
    Transplantation; 1990 Jan 25; 49(1):30-4. PubMed ID: 2301023
    [Abstract] [Full Text] [Related]

  • 37. Differentiation between allograft rejection and cyclosporin nephrotoxicity in renal-transplant recipients.
    Taube DH, Neild GH, Williams DG, Cameron JS, Hartley B, Ogg CS, Rudge CJ, Welsh KI.
    Lancet; 1985 Jul 27; 2(8448):171-4. PubMed ID: 2862369
    [Abstract] [Full Text] [Related]

  • 38. Steady-state concentrations of cyclosporine for therapeutic monitoring.
    Grevel J, Napoli KL, Kahan BD.
    Transplant Proc; 1990 Jun 27; 22(3):1339-42. PubMed ID: 2190397
    [No Abstract] [Full Text] [Related]

  • 39. Blood cyclosporin concentrations and renal allograft dysfunction.
    Holt DW, Marsden JT, Johnston A, Bewick M, Taube DH.
    Br Med J (Clin Res Ed); 1986 Oct 25; 293(6554):1057-9. PubMed ID: 3094774
    [Abstract] [Full Text] [Related]

  • 40. Fine-needle aspiration cytology monitoring of elective conversion from cyclosporin to azathioprine and prednisolone.
    Ubhi CS, Baker JM, Guillou PJ, Giles GR, Davison AM, Will EJ.
    Nephrol Dial Transplant; 1988 Oct 25; 3(4):453-7. PubMed ID: 3140133
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.